Biostatistics & Statistical Programming
Data-Driven Precision From Design to Submission
Drive Trial Success
Our biostatistics team supports your study from design to analysis — calculating sample size, managing randomization, and interpreting results to ensure scientific rigor and meaningful outcomes.
Expert Analysis at Every Stage
Our Proof of Quality
We are ISO 9001 and ISO 27001 certified. Our commitment to robust information security & superior quality management is at the core of our innovative solutions, ensuring reliable & efficient trial management for our clients.
Main Areas of Biostatistics & Statistical Programming
Wemedoo’s biostatistics team ensures accuracy from trial design to reporting, with expert analysis, in-house quality control, and regulatory compliance—delivering reliable, data-driven results you can trust.
Our biostatisticians perform sample size calculations by assessing study objectives and provide support for clients through systematic literature reviews (especially if the effect size is uncertain). Every sample size calculation process is validated, ensuring accuracy and providing a solid foundation for your clinical trial.
Trusted partners
Global network of partners
Benefits of Our Service
Wemedoo combines expert biostatistics, clinical programming, data management, and medical writing to deliver precise, compliant results. With strong CDISC knowledge and advanced tools, we minimize risks, accelerate timelines, and give clients a competitive edge.
Exploit the Perks of Our Clinical Biostatistics & Statistical programming services
Decision Making
With advanced biostatistics services, we empower informed decision-making through data analysis, that allows you to gain strategic insights and enhance research development.
Regulatory Compliance
Our services give an advantage to navigate regulatory requirements without any issues, ensuring adherence to high statistical standards and expediting the approval process.
Maximum Validity
Wemedoo’s biostatistics services ensure rigorous analysis, integrity and credibility of the research findings.
Accurate Data Analysis
Our biostatistics solutions deliver complete statistical analysis to ensure the validity and accuracy of your data and research outcomes.
Looking for Clinical Trial Support That Fits Your Study?
Explore how our flexible, integrated services can help you accelerate timelines, improve quality, and reduce complexity.
Frequently Asked Questions
Get the answers you need about our biostatistics and statistical programming services
At what stage of a clinical study does Wemedoo provide biostatistical services?
Our expert team provides support in the early stages of protocol development, with sample size calculation and randomization algorithms. During data collection, our team can provide interim analysis services and sample size re-estimation calculations and randomization list extensions, as well as statistical analysis planning. After data collection, we provide a full statistical programming and analysis services, together with reporting.
How does Wemedoo ensure reliability of study results?
Every service we provide is conducted by expert biostatisticians and clinical programmers with many years of experience in clinical trials. All our processes are completed with our extensive QA/QC processes.
How long does statistical analysis take after data collection is complete?
Thanks to the amazing collaborative strength between data managers and medical writers, biostatisticians, and clinical programmers, statistical programming and preparatory activities are conducted while data collection is ongoing. This significantly reduces timelines for statistical deliverables after database lock and export.
How does Wemedoo ensure regulatory compliance of statistical analysis results?
Ensuring regulatory compliance in statistical analysis is our priority. Rigorous validation processes, aligned with our company's high standards and industry-leading regulatory validation programs, are integral to our practices. All our statistical processes are aligned with regulatory guidelines and recommendations, including ICH E9, among others sounds smoother. Additionally, our biostatisticians and statistical programmers are true scientists with PhD degrees, and perform literature reviews for state-of-the-art procedures and continuous education.
Wondering How It All Works?
Learn more about how we can support your clinical trials.
SPEAK TO AN EXPERT Explore Related Services
Beyond protocol development, Wemedoo offers a comprehensive suite of integrated data operations services for clinical trials. At each step, we ensure your trial meets the highest quality and regulatory standards, while streamlining your clinical trial processes and saving you time and money. Discover our other services, all focusing on innovation and excellence in clinical research.
Resources
Biostatistics & programming resources
Biostatistics & Programming
Wemedoo returns to Xraised episode 2 with unified data in focus
July 9, 2026
Artificial Intelligence in Clinical Trials: Balancing Innovation and Accuracy
June 24, 2026
A new scientific publication featuring Wemedoo researchers has been published in BMC Medical Research Methodology
June 24, 2026
The CRO’s Guide to Winning Sponsor Trust
June 24, 2026
Key Takeaways from EUCROF25: AI, Integration, and CRO Challenges in Clinical Trials
June 24, 2026
Wemedoo Becomes an Associate Member of EUCROF
June 24, 2026
Across Global Alliance Selects oomnia as a Central Trial Infrastructure
June 24, 2026
Revolutionizing Clinical Trials: How Wemedoo is Accelerating Global Research
June 24, 2026
Why does unified data matter? Hear from Wemedoo at Swiss Biotech Day!
June 24, 2026
Wemedoo in The CEO Magazine: Fixing Clinical Trials
June 24, 2026
Wemedoo in Forbes: From Clinical Frustration to Real Innovation
June 24, 2026
New Era of Clinical Trials with oomnia®: Built for Complexity, Designed for Simplicity
June 24, 2026
Dr. Nikola Cihoric elected to EUCROF AI Expert Group
June 24, 2026
Wemedoo announces strategic partnership with mediri to streamline imaging data management in clinical trials
June 24, 2026
Wemedoo’s innovation journey with oomnia on Xraised
June 24, 2026
The hidden cost of disconnected systems in biotech and the path to streamlined trials
June 24, 2026
Wemedoo receives SCDM innovator start-up of the year 2025 award
June 24, 2026
Wemedoo featured on BioSpace
June 24, 2026
Wemedoo joins Xraised again to share new perspectives
June 24, 2026
Wemedoo featured on AP News
June 24, 2026
Clinical trial trends in 2025
June 24, 2026
Why eClinical architectures have reached their limits, and a new category is emerging
June 24, 2026
Why compliance risk increases in modular eClinical setups
June 24, 2026
What makes a clinical trial software truly unified
June 24, 2026
Top EDC software solutions for clinical trial teams
June 24, 2026
oomnia - Meeting Industry Standards
Our unified clinical trial software is designed with compliance at its core, meeting critical industry standards. Our commitment to these regulations ensures that your clinical trials are not only efficient but also adhere to the highest levels of data integrity, privacy, and ethical conduct.
compliant
compliant
compliant
compliant
compliant
compliant
See What Our Clients Say
Read more about the experiences from those who have partnered with us
All jobs, both large and small, are performed with the same dedication to quality, detail, innovative thinking, and rigor. It is always a pleasure to work with the Wemedoo team.
Georg Mathis, PhD
CEO Appletree CI Group AG
Wemedoo embodies all the traits desired in a partner in the clinical trial industry – expertise, innovation, reliability, compliance, and attention to detail.
Martina Diminic Smetisko, DMD
Managing Director at Marti Farm Ltd
Their dedication to, and support of, our projects has resulted in clear quality deliverables. They are always there to answer any questions with expertise in a timely manner. I am...
Their dedication to, and support of, our projects has resulted in clear quality deliverables. They are always there to answer any questions with expertise in a timely manner. I am looking forward to our next project together.
Volodymyr Stus, MD
Biopharmaceutics and Clinical Research Department Manager at Polpharma SA
Wemedoo's cross-functional, integrated teams capture EDC set-up, go-live, data capture, data cleaning, and finally data analysis in a globally compliant fashion supporting trials in different geographies including the US. Their...
Wemedoo's cross-functional, integrated teams capture EDC set-up, go-live, data capture, data cleaning, and finally data analysis in a globally compliant fashion supporting trials in different geographies including the US. Their speed of addressing customer needs sets in my personal experience industry benchmark whilst keeping these data solutions lean and affordable. Besides the great proprietary systems they use, their integrated team approach with personal responsibility and honest commitment to targeting outcomes differentiates the Wemedoo team from other providers. Wemedoo only made Oxular's key initial trial, a device-drug trial possible, as based on some pre-work, the Wemedoo team could substantially adapt and update the first EDC ideas for a trial under a US FDA IND. The Wemedoo team worked extremely focused on familiarizing US trial sites and clinical CROs with the use of their system, which turned out to be a key success factor of the respective trial. The highly professional and up-to-date capabilities in data sciences were mirrored by customer-centricity and super fast timelines of integrating mandatory adaptations to the data systems.
Friedrich Asmus, MD
Chief Medical Officer at Oxular
Wemedoo's technology, expertise, and intimate engagement with our team in the development of the EDC, site/patient interface, and metric capabilities are unique. They provided insight and challenged the underlying assumptions...
Wemedoo's technology, expertise, and intimate engagement with our team in the development of the EDC, site/patient interface, and metric capabilities are unique. They provided insight and challenged the underlying assumptions to ensure the study's goals and objectives were clearly defined and the operating structure matched with the study's intent. Their system is not a one-size-fits-all and they adapt to the needs of the sponsor, sites, physicians, and the study requirements into a system that merges health information/data and can then become not only informative but actionable.
James Kuras
Vice President of Clinical Affairs and Operations at CENTINEL SPINE
Considering Unified Clinical Trial Software?
Experience oomnia, our all-in-one clinical trial software which unifies tools, such as EDC, eSource, RTSM, eTMF, ePRO, eCOA, eConsent, and CTMS. In combination with our professional services, we can provide end-to-end support to transform your clinical research.
BOOK A DEMO